Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV

By Josh Enomoto, InvestorPlace Contributor

AbbVie has significant challenges, but they’re also not unique ones. Sizing up the outlook leads to a slightly bullish stance on ABBV stock.

3 Reasons Why Facebook’s Scandal Can’t Touch FB Stock

By Josh Enomoto, InvestorPlace Contributor

FB stock appears headed towards implosion after another scandal, but the company is simply too dominant to undo.

10 Marijuana Stocks to Ride High on the Farm Bill

By Josh Enomoto, InvestorPlace Contributor

Marijuana stocks have recently lagged the markets, but the newly signed farm bill provides a significant catalyst for pot businesses.

3 Reasons Why You Should Hold Off on Chevron Stock

By Josh Enomoto, InvestorPlace Contributor

Chevron stock offers several positives in this down market, but three major headwinds make CVX a difficult proposition.

The Weakness of Micron Stock Has Created a Good Buying Opportunity

By Josh Enomoto, InvestorPlace Contributor

MU stock absorbed a devastating hit after a disappointing Q1 earnings report, but the longer-term outlook of Micron stock is upbeat.

Load More